Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences?

health services research qualitative research quality indicators, health care

Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
03 2022
Historique:
received: 27 11 2021
accepted: 09 02 2022
entrez: 5 3 2022
pubmed: 6 3 2022
medline: 7 4 2022
Statut: ppublish

Résumé

To obtain an overview of gender equity at European rheumatology conferences. The proportion of women invited as either moderators or speakers to the European Alliance of Associations for Rheumatology (EULAR) annual congresses and national conferences in Europe was calculated from the published congress materials from EULAR annual congresses (2015-2019) and the 2019 national conferences of France, Germany, Italy, Spain and the UK. Data from EULAR congresses were further categorised by type of session. Significance testing was conducted using χ The proportion of combined women moderators and speakers at EULAR varied from 40% to 43% between 2015 and 2019 with no obvious trend over time. There were higher proportions of women in the Health Professionals in Rheumatology and People with Arthritis and Rheumatism sessions (>50% consistently). However, these sessions represent <25% of EULAR congress invitations. Representation of women at the EULAR congress in 2019 (39.6%) was significantly higher than at the national congresses in France (28.6%) and Germany (29.6%) but similar to that observed in Italy (33.7%), Spain (41.7%) and the UK (42%). Women account for less than half of invited moderators and speakers at the conferences reviewed. Compared with historical EULAR data in 2003 (16%) and in 2004 (19%), the gender gap at EULAR congresses has narrowed considerably, but there remains a need to monitor and improve women's representation.

Identifiants

pubmed: 35246471
pii: rmdopen-2021-002131
doi: 10.1136/rmdopen-2021-002131
pmc: PMC8900061
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/V00199X/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Joint Bone Spine. 2019 Nov;86(6):669-672
pubmed: 31220622
JAMA Netw Open. 2020 Sep 1;3(9):e2018127
pubmed: 32986107
Lancet. 2016 Dec 10;388(10062):2948-2958
pubmed: 27105721
Ann Rheum Dis. 2020 Aug 4;:
pubmed: 32753419
Lancet. 2019 Feb 9;393(10171):e14
pubmed: 30739700
Hum Resour Health. 2017 Jan 6;15(1):2
pubmed: 28061790
J Autoimmun. 2007 Feb;28(1):1-6
pubmed: 17261360
Reumatismo. 2020 Jan 28;71(4):173-176
pubmed: 31995955
Arthritis Rheum. 2005 Mar;52(3):697-706
pubmed: 15751096
BMJ Open. 2020 Jan 15;10(1):e032232
pubmed: 31948988
Arthritis Care Res (Hoboken). 2018 Apr;70(4):617-626
pubmed: 29400009
Ann Rheum Dis. 2020 May 13;:
pubmed: 32404339
Ann Rheum Dis. 2020 Aug;79(8):1122-1123
pubmed: 32102797
Arthritis Rheumatol. 2021 Jan;73(1):162-167
pubmed: 32812398

Auteurs

Neelam Hassan (N)

Musculoskeletal Research Unit, University of Bristol, Bristol, UK.
Department of Rheumatology, North Bristol NHS Trust, Bristol, UK.

Leonieke Jj van Mens (LJ)

Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Uta Kiltz (U)

Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany.

Laura Andreoli (L)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Brescia, Italy.

Concha Delgado-Beltran (C)

Rheumatology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

Pavel V Ovseiko (PV)

Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Laure Gossec (L)

INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.
APHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France.

Laura C Coates (LC)

NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK laura.coates@ndorms.ox.ac.uk.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH